This is the authors' abstract. We don't add key points for this paper.
The interactome in normal and disease cells is a key area for study and therapeutic targeting, yet few molecules have been developed that can interfere with protein–protein interactions within cells. Peptides and homologues are potential reagents to target PPI.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Cruz-Migoni et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: